BMKDF
Price:
$0.3978
Market Cap:
$57.80M
BioMark Diagnostics Inc. is an oncology-focused firm that develops sophisticated diagnostic tools for cancer. These solutions are designed to aid in the identification of the disease, its ongoing monitoring, and the assessment of initial therapeutic interventions. The company has a research partnership with the Icahn School of Medicine, under which they conduct clinical studies concentrating on the early detection of lung cancer. Established in 2014, BioMark Diagnostics Inc. has its main office in Richmond, Canada, and functions as a subsidiary of Biomark Technologies Inc.
Industry
Medical - Diagnostics & Research
IPO Date
2015-03-23
Stock Exchange
OTC
Ticker
BMKDF
According to BioMark Diagnostics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 58.02M. This represents a change of 66.96% compared to the average of 34.75M of the last 4 quarters.
The mean historical Enterprise Value of BioMark Diagnostics Inc. over the last ten years is 14.70M. The current 58.02M Enterprise Value has changed 39.36% with respect to the historical average. Over the past ten years (40 quarters), BMKDF's Enterprise Value was at its highest in in the December 2025 quarter at 49.62M. The Enterprise Value was at its lowest in in the December 2018 quarter at 3.80M.
Average
14.70M
Median
14.76M
Minimum
4.26M
Maximum
30.03M
Discovering the peaks and valleys of BioMark Diagnostics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 186.79%
Maximum Annual Enterprise Value = 30.03M
Minimum Annual Increase = -42.39%
Minimum Annual Enterprise Value = 4.26M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 20.99M | -22.16% |
| 2024 | 26.96M | 48.66% |
| 2023 | 18.14M | 4.83% |
| 2022 | 17.30M | -42.39% |
| 2021 | 30.03M | 145.54% |
| 2020 | 12.23M | 186.79% |
| 2019 | 4.26M | -11.04% |
| 2018 | 4.79M | -6.56% |
| 2017 | 5.13M | -28.72% |
| 2016 | 7.20M | -27.59% |
The current Enterprise Value of BioMark Diagnostics Inc. (BMKDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.03M
5-year avg
22.68M
10-year avg
14.70M
BioMark Diagnostics Inc.’s Enterprise Value is greater than Cordlife Group Limited (22.62M), greater than Izotropic Corporation (20.71M), greater than Marpai, Inc. (11.84M), greater than ImpediMed Limited (14.78M), greater than DIAGNOS Inc. (21.98M), less than Fluent Corp. (148.26M), greater than Evolva Holding S.A. (6.72M), greater than Celyad Oncology S.A. (10.02M), greater than Rubicon Organics Inc. (41.13M), less than Starpharma Holdings Limited (262.46M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 22.62M | $38.57M | |
| 20.71M | $12.42M | |
| 11.84M | $11.31M | |
| 14.78M | $13.80M | |
| 21.98M | $14.26M | |
| 148.26M | $10.77M | |
| 6.72M | $7.93M | |
| 10.02M | $11.19M | |
| 41.13M | $22.50M | |
| 262.46M | $227.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMark Diagnostics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioMark Diagnostics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioMark Diagnostics Inc.'s Enterprise Value?
What is the highest Enterprise Value for BioMark Diagnostics Inc. (BMKDF)?
What is the 3-year average Enterprise Value for BioMark Diagnostics Inc. (BMKDF)?
What is the 5-year average Enterprise Value for BioMark Diagnostics Inc. (BMKDF)?
How does the current Enterprise Value for BioMark Diagnostics Inc. (BMKDF) compare to its historical average?